Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Chief Tech/Sci/R&D Officer - 17/07/2009
Director of Finance/CFO 60 01/07/2022
Director TitleAgeSince
Director/Board Member 58 09/07/2020
Chairman 68 09/12/2021
Director/Board Member 78 01/09/2004
Date Insider Type Main position Quantity % Market Cap. Importance
09/07/20 Tender

Chief Executive Officer

29,206 0.1196%
09/07/20 Tender

Chief Financial Officer

500 0.0020% -
09/07/20 Tender

Director

1,02,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 14.13L
+2.67%-0.87%-25.63%+4.05% 17TCr
+1.84%-1.71%-9.96%+15.52% 11TCr
+3.55%+3.60%-23.02%+7.71% 11TCr
+1.14%+1.18%-47.01%-10.83% 7.44TCr
+1.90%+3.66%+4.02%+70.20% 6.01TCr
+3.27%+8.93%+12.12%+69.34% 5.19TCr
+2.19%-1.72%-6.68%-30.79% 4.92TCr
+1.67%-0.38%-16.50%+22.43% 4.15TCr
+1.80%+0.25%+29.60%+3.45% 3.28TCr
Average +0.90%+0.62%-9.23%+16.79% 7.83TCr
Weighted average by Cap. +0.44%+0.42%-15.25%+13.94%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-